AKAP12 anticorps (AA 1719-1782)
Aperçu rapide pour AKAP12 anticorps (AA 1719-1782) (ABIN1886110)
Antigène
Voir toutes AKAP12 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1719-1782
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Synthetic peptide contain a sequence corresponding to a region within amino acids 1719 and 1782 of AKAP12
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.250
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- AKAP12 (A Kinase (PRKA) Anchor Protein 12 (AKAP12))
-
Autre désignation
- AKAP12
-
Sujet
-
The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins, which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell.This gene encodes a member of the AKAP family.The encoded protein is expressed in endothelial cells, cultured fibroblasts, and osteosarcoma cells.It associates with protein kinases A and C and phosphatase, and serves as a scaffold protein in signal transduction.This protein and RII PKA colocalize at the cell periphery.This protein is a cell growth-related protein.Antibodies to this protein can be produced by patients with myasthenia gravis.Alternative splicing of this gene results in two transcript variants encoding different isoforms.[provided by RefSeq]
-
Poids moléculaire
- 192 kDa
-
ID gène
- 9590
-
NCBI Accession
- NM_005100, NP_005091
-
Pathways
- cAMP Metabolic Process
Antigène
-